Recently, upregulation of PFKFB3 has been reported in PASMCs from PAH patients and animal models, and it participates in PAH development by promoting PASMC proliferation and pulmonary vascular remodeling (14, 15). Here, PFKFB3 is linked to pulmonary arterial hypertension.